{"id":"https://openalex.org/W4407698693","doi":"https://doi.org/10.70534/pdtu1372","title":"Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis","display_name":"Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis","alternate_titles":[],"publication_year":2024,"publication_date":"2024-01-01","ids":{"openalex":"https://openalex.org/W4407698693","doi":"https://doi.org/10.70534/pdtu1372"},"language":"en","primary_location":{"id":"doi:10.70534/pdtu1372","doi":"https://doi.org/10.70534/pdtu1372","is_oa":true,"landing_page_url":"https://doi.org/10.70534/pdtu1372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis","raw_type":"proceedings-article"},"parent_works":[],"lineage":["https://openalex.org/W4407698693"],"child_works_count":0,"type":"conference-paper","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.70534/pdtu1372","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044457398","display_name":"Jomana Al Hroot","orcid":"https://orcid.org/0009-0003-4136-4409","observed_orcids":["https://orcid.org/0009-0003-4136-4409"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jomana Al Hroot","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051945295","display_name":"Guohua An","orcid":"https://orcid.org/0000-0002-6498-7663","observed_orcids":["https://orcid.org/0000-0002-6498-7663"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Guohua An","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041616368","display_name":"Kenan Gu","orcid":"https://orcid.org/0009-0001-9621-8439","observed_orcids":["https://orcid.org/0009-0001-9621-8439"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kenan Gu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077732787","display_name":"Xuanzhen Yuan","orcid":"https://orcid.org/0009-0008-3510-691X","observed_orcids":["https://orcid.org/0009-0008-3510-691X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuanzhen Yuan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5007385934","display_name":"Joshua A. Reeder","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joshua Reeder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11036","display_name":"Antibiotics Pharmacokinetics and Efficacy","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10654","display_name":"Pneumonia and Respiratory Infections","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fosfomycin","display_name":"fosfomycin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/dosing-regimen-optimization","display_name":"dosing regimen optimization","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pneumonia","display_name":"pneumonia","score":0.8949999809265137},{"id":"https://openalex.org/keywords/epithelial-lining-fluid","display_name":"epithelial lining fluid","score":0.8220000267028809},{"id":"https://openalex.org/keywords/alveolar-macrophages","display_name":"alveolar macrophages","score":0.9990000128746033},{"id":"https://openalex.org/keywords/interstitial-fluid","display_name":"interstitial fluid","score":0.8450000286102295},{"id":"https://openalex.org/keywords/probability-of-target-attainment","display_name":"probability of target attainment","score":0.7789999842643738},{"id":"https://openalex.org/keywords/antimicrobial-resistance","display_name":"antimicrobial resistance","score":0.8539999723434448},{"id":"https://openalex.org/keywords/eskape-pathogens","display_name":"ESKAPE pathogens","score":0.9629999995231628},{"id":"https://openalex.org/keywords/monte-carlo-simulation","display_name":"Monte Carlo simulation","score":0.6349999904632568},{"id":"https://openalex.org/keywords/lower-respiratory-tract-infection","display_name":"lower respiratory tract infection","score":0.5820000171661377},{"id":"https://openalex.org/keywords/drug-concentration-prediction","display_name":"drug concentration prediction","score":0.31299999356269836}],"concepts":[{"id":"https://openalex.org/C2778897966","wikidata":"https://www.wikidata.org/wiki/Q183554","display_name":"Fosfomycin","level":3,"score":0.7502923011779785},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.63752681016922},{"id":"https://openalex.org/C185867374","wikidata":"https://www.wikidata.org/wiki/Q2562769","display_name":"Physiologically based pharmacokinetic modelling","level":3,"score":0.6013649702072144},{"id":"https://openalex.org/C2777914695","wikidata":"https://www.wikidata.org/wiki/Q12192","display_name":"Pneumonia","level":2,"score":0.5406131744384766},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5200978517532349},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4680136442184448},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.3973310589790344},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.38776326179504395},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3520233929157257},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3028680980205536},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.27942872047424316},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.19980448484420776},{"id":"https://openalex.org/C501593827","wikidata":"https://www.wikidata.org/wiki/Q12187","display_name":"Antibiotics","level":2,"score":0.17452815175056458},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.70534/pdtu1372","doi":"https://doi.org/10.70534/pdtu1372","is_oa":true,"landing_page_url":"https://doi.org/10.70534/pdtu1372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis","raw_type":"proceedings-article"}],"best_oa_location":{"id":"doi:10.70534/pdtu1372","doi":"https://doi.org/10.70534/pdtu1372","is_oa":true,"landing_page_url":"https://doi.org/10.70534/pdtu1372","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Determining an Appropriate Fosfomycin Dosing Regimen in Pneumonia Patients by Utilizing minimal PBPK Modeling and Target Attainment Analysis","raw_type":"proceedings-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4410079697","https://openalex.org/W4365810803","https://openalex.org/W2993296458","https://openalex.org/W4389032030","https://openalex.org/W2785603054","https://openalex.org/W2955555782","https://openalex.org/W4367600516","https://openalex.org/W7217543535","https://openalex.org/W2473630156","https://openalex.org/W4389899763"],"abstract_inverted_index":{"Objective:":[0],"Antimicrobial":[1],"resistance":[2],"(AMR)":[3],"poses":[4],"a":[5,24,61,126,133,396],"significant":[6],"global":[7],"health":[8],"threat,":[9],"especially":[10],"with":[11,377],"pathogens":[12,41],"like":[13,153],"the":[14,50,58,88,96,108,154,169,193,264,288,299,305,316,327,363,368,384,392,403],"ESKAPE":[15],"group,":[16],"known":[17,46],"for":[18,120,182,276,419,432],"causing":[19],"severe":[20],"infections,":[21],"including":[22],"pneumonia,":[23],"lower":[25,373],"respiratory":[26],"tract":[27],"infection":[28,151,166,265,337],"(":[29,42,52],"1).":[30],"Fosfomycin":[31],"has":[32],"been":[33],"reported":[34],"to":[35,47,55,114,122,142,177,234,244,256,375,415],"treat":[36],"such":[37],"kind":[38],"of":[39,171,175,209,229,287],"resistant":[40],"2)":[43],"and":[44,90,101,148,156,167,190,204,212,225,240,247,267,281,307,318,323,354,370,395],"is":[45],"rapidly":[48],"penetrate":[49],"lungs":[51],"3).":[53],"Due":[54],"these":[56,230,329],"facts,":[57],"NIH":[59],"conducted":[60,255],"phase":[62,127],"1":[63],"clinical":[64,129],"study":[65,130,389,416],"on":[66,260],"fosfomycin":[67,121,176],"(ZTI-01).":[68],"Thirty":[69],"healthy":[70],"participants":[71],"were":[72,85,105,188,232,242,254,291,321,372],"given":[73],"6":[74],"g":[75],"dose":[76,385,398],"every":[77],"8":[78],"hours":[79],"via":[80],"IV":[81],"infusion.":[82],"Blood":[83],"samples":[84],"collected":[86],"after":[87,107],"first":[89],"third":[91,109],"doses,":[92],"while":[93],"intrapulmonary":[94,417],"samples,":[95],"Epithelial":[97],"Lining":[98],"Fluid":[99,222],"(ELF)":[100],"Alveolar":[102],"Macrophages":[103],"(AM)":[104],"obtained":[106],"dose.":[110],"This":[111],"project":[112],"aims":[113],"propose":[115],"an":[116],"appropriate":[117],"dosing":[118,180,430],"regimen":[119],"be":[123,400,412],"used":[124,275,386,414],"in":[125,146,149,162,201,315,351,367,380,387,402,429],"2":[128],"by":[131],"using":[132],"mechanistic,":[134],"minimal":[135,194,277],"physiologically":[136],"based":[137],"pharmacokinetics":[138,418],"(minimal":[139],"PBPK)":[140],"model":[141,196,207,279,290,408],"predict":[143],"drug":[144,163,199,261,346,358],"concentrations":[145,200,262,366],"plasma,":[147,202,376],"major":[150],"sites":[152],"ELF":[155,308,317,352,369],"AM.":[157,205,226],"Furthermore,":[158],"it":[159],"examines":[160],"changes":[161,350],"concentration":[164],"during":[165],"predicts":[168],"probability":[170],"target":[172,394],"attainment":[173],"(PTA)":[174],"identify":[178],"optimal":[179],"regimens":[181],"pneumonia":[183,381,434],"patients.":[184,382],"Methods:":[185],"Different":[186],"models":[187],"evaluated,":[189],"among":[191],"them,":[192],"PBPK":[195,278],"successfully":[197],"captured":[198],"ELF,":[203,224,239],"The":[206,215,227,284,293,312],"consisted":[208],"Plasma,":[210],"Tissue,":[211],"Lung":[213,216],"compartments.":[214],"compartment":[217],"includes":[218],"lung":[219,319],"tissues,":[220],"Interstitial":[221],"(ISF),":[223],"volumes":[228],"compartments":[231],"fixed":[233],"physiological":[235],"values;":[236],"specifically,":[237],"ISF,":[238],"AM":[241,371],"set":[243],"0.026,":[245],"0.0026,":[246],"0.3":[248],"L,":[249],"respectively.":[250,325],"Monte":[251],"Carlo":[252],"simulations":[253],"evaluate":[257],"pneumonia\u2019s":[258],"impact":[259],"at":[263],"site":[266,338],"PTA":[268,424],"against":[269],"various":[270],"pathogens.":[271],"NONMEM":[272],"7.4.3":[273],"was":[274,296,309],"estimation":[280],"simulation.":[282],"Results:":[283],"PK":[285],"parameters":[286,330],"proposed":[289],"estimated.":[292],"systematic":[294],"clearance":[295],"6.17":[297],"L/hr,":[298],"permeability":[300,343],"surface":[301],"product":[302],"(PS)":[303],"between":[304],"ISF":[306],"0.0316":[310],"L/hr.":[311],"partition":[313,355],"coefficients":[314,356],"tissues":[320],"0.39":[322],"11.6,":[324],"During":[326],"infection,":[328],"change,":[331],"but":[332],"this":[333],"doesn\u2019t":[334],"always":[335],"alter":[336],"concentrations.":[339],"Increased":[340],"alveolar":[341],"membrane":[342],"didn\u2019t":[344,390],"affect":[345],"levels":[347],"there.":[348],"However,":[349],"volume":[353],"reduced":[357],"concentrations.Plasma":[359],"data":[360],"alone":[361],"overestimated":[362],"effectiveness,":[364],"as":[365],"compared":[374],"further":[378],"reductions":[379],"Therefore,":[383],"phase1":[388],"achieve":[391],"PK/PD":[393],"higher":[397],"should":[399],"considered":[401],"subsequent":[404],"trial.":[405],"Conclusion:":[406],"Our":[407],"structure":[409],"can":[410,426],"also":[411,413],"other":[420],"antibiotics.":[421],"Additionally,":[422],"our":[423],"results":[425],"guide":[427],"physicians":[428],"decisions":[431],"different":[433],"stages.":[435]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4407698693","counts_by_year":[],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2025-02-19T00:00:00"}
